{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:39:33Z","timestamp":1762004373941},"publisher-location":"Berlin, Heidelberg","reference-count":32,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642324413"},{"type":"electronic","value":"9783642324420"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/8904_2012_132","type":"book-chapter","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T16:28:42Z","timestamp":1332520122000},"page":"7-12","source":"Crossref","is-referenced-by-count":1,"title":["Temporal Intradiploic Dilative Vasculopathy: An Additional Pathogenic Factor for the Hearing Loss in Fabry Disease?"],"prefix":"10.1007","author":[{"given":"Carla Pinto","family":"Moura","sequence":"first","affiliation":[]},{"given":"Carlos","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Daniela","family":"Seixas","sequence":"additional","affiliation":[]},{"given":"Margarida","family":"Ayres-Bastos","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Paulo","family":"Oliveira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,3,24]]},"reference":[{"key":"132_CR1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2214\/ajr.164.3.7863894","volume":"164","author":"D Bastug","year":"1995","unstructured":"Bastug D, Ortiz O, Schoclet S (1995) Hemangiomas in the calvaria: imaging findings. AJR Am J Roentgenol 164:683\u2013687","journal-title":"AJR Am J Roentgenol"},{"key":"132_CR2","first-page":"1865","volume":"10","author":"C Bazzi","year":"1995","unstructured":"Bazzi C, Venturini CT, Pagani C, Arrigo G, D'Amico G (1995) Hearing loss in short-and long-term haemodialysed patients. Nephrol Dial Transplant 10:1865\u20131868","journal-title":"Nephrol Dial Transplant"},{"issue":"443","key":"132_CR3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1651-2227.2003.tb00219.x","volume":"92","author":"G Conti","year":"2003","unstructured":"Conti G, Sergi B (2003) Auditory and vestibular findings in Fabry disease: a study of hemizygous males and heterozygous females. Acta Pediatr Suppl 92(443):33\u201337, discussion 27","journal-title":"Acta Pediatr Suppl"},{"key":"132_CR4","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1212\/WNL.50.6.1746","volume":"50","author":"KE Crutchfield","year":"1998","unstructured":"Crutchfield KE, Patronas NJ, Dambrosia JM et al (1998) Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurology 50:1746\u20131749","journal-title":"Neurology"},{"key":"132_CR5","first-page":"3733","volume-title":"The metabolic and molecular bases of inherited disease","author":"RJ Desnick","year":"2001","unstructured":"Desnick RJ, Ioannou YA, Eng CM (2001) Alpha-galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Kinzler KE, Vogelstein B (eds) The metabolic and molecular bases of inherited disease. McGraw Hill, New York, pp 3733\u20133774"},{"key":"132_CR6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","volume":"138","author":"RJ Desnick","year":"2003","unstructured":"Desnick RJ, Brady R, Barranger J et al (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338\u2013436","journal-title":"Ann Intern Med"},{"key":"132_CR7","first-page":"250","volume":"23","author":"JJ Dufour","year":"1994","unstructured":"Dufour JJ, Michaud LA, Mohr G, Pouliot D, Picard C (1994) Intratemporal vascular malformations (angiomas): particular clinical features. J Otolaryngol 23:250\u2013253","journal-title":"J Otolaryngol"},{"key":"132_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR, International Collaborative Fabry Disease Study Group et al (2001) Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry's disease. N Engl J Med 345:9\u201316","journal-title":"N Engl J Med"},{"key":"132_CR9","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(06)70548-8","volume":"5","author":"A Fellgiebel","year":"2006","unstructured":"Fellgiebel A, M\u00fcller MJ, Ginsberg L (2006) CNS manifestations of Fabry\u2019s disease. Lancet Neurol 5:791\u2013795","journal-title":"Lancet Neurol"},{"key":"132_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2350-3-10","volume":"3","author":"D Germain","year":"2002","unstructured":"Germain D, Avan P, Chassaing A, Bonfils P (2002) Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients. BMC Med Genet 3:10","journal-title":"BMC Med Genet"},{"issue":"443","key":"132_CR11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1651-2227.2003.tb00217.x","volume":"92","author":"D Hajioff","year":"2003","unstructured":"Hajioff D, Goodwin S, Quiney R, Zuckerman J, MacDermot KD, Mehta A (2003a) Hearing improvement in patients with Fabry disease treated with agalsidase alfa. Acta Paediatr Suppl 92(443):28\u201330, discussion 27","journal-title":"Acta Paediatr Suppl"},{"key":"132_CR12","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1023\/B:BOLI.0000009948.86528.72","volume":"26","author":"D Hajioff","year":"2003","unstructured":"Hajioff D, Enever Y, Quiney R, Zuckerman J, MacDermot K, Mehta A (2003b) Hearing loss in Fabry disease: the effect of agalsidase alfa replacement therapy. J Inher Metab Dis 26:787\u2013794","journal-title":"J Inher Metab Dis"},{"key":"132_CR13","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1365-2362.2006.01702.x","volume":"36","author":"S Hegemann","year":"2006","unstructured":"Hegemann S, Hajioff D, Conti G et al (2006) Hearing loss in Fabry disease: data from the Fabry Outcome Survey. Eur J Clin Invest 36:654\u2013662","journal-title":"Eur J Clin Invest"},{"key":"132_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.01.011","volume":"18","author":"H Ichikawa","year":"2009","unstructured":"Ichikawa H, Takahashi N, Mukai M, Katoh H, Akizawa T, Kawamura M (2009) Intracranial dilative arteriopathy is associated with chronic kidney disease and small vessel diseases in the elderly. J Stroke Cerebrovasc Dis 18:435\u2013442","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"132_CR15","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1212\/WNL.50.6.1694","volume":"50","author":"B Ince","year":"1998","unstructured":"Ince B, Petty GW, Brown RD Jr, Chu CP, Sicks JD, Whisnant JP (1998) Dolichoectasia of the intracranial arteries in patients with first ischemic stroke: a population-based study. Neurology 50:1694\u20131998","journal-title":"Neurology"},{"key":"132_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s10545-009-1290-x","volume":"32","author":"A Keilmann","year":"2009","unstructured":"Keilmann A, Hajioff D, Ramaswami U, FOS Investigators (2009) Ear symptoms in children with Fabry disease: data from the Fabry Outcome Survey. J Inherit Metab Dis 32:739\u2013744","journal-title":"J Inherit Metab Dis"},{"key":"132_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1288\/00005537-198104000-00011","volume":"91","author":"AB Kligerman","year":"1981","unstructured":"Kligerman AB, Solangi KB, Ventry IM, Goodman AI, Weseley SA (1981) Hearing impairment associated with chronic renal failure. Laryngoscope 91:583\u2013592","journal-title":"Laryngoscope"},{"key":"132_CR18","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/j.1523-1755.2004.00883.x","volume":"66","author":"M Kosch","year":"2004","unstructured":"Kosch M, Koch HG, Oliveira JP et al (2004) Enzyme replacement therapy administered during hemodialysis in patients with Fabry disease. Kidney Int 66:1279\u20131282","journal-title":"Kidney Int"},{"key":"132_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/glycob\/cwg034","volume":"13","author":"K Lee","year":"2003","unstructured":"Lee K, Jin X, Zhang K et al (2003) A biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry disease. Glycobiology 13:305\u2013313","journal-title":"Glycobiology"},{"key":"132_CR20","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1111\/j.1523-1755.2004.00924.x","volume":"66","author":"G Linthorst","year":"2004","unstructured":"Linthorst G, Hollak C, Donker-Koopman W, Strijland A, Aerts J (2004) Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and beta. Kidney Int 66:1589\u20131595","journal-title":"Kidney Int"},{"key":"132_CR21","first-page":"288","volume":"19","author":"GJ Madden","year":"1990","unstructured":"Madden GJ, Sirimina KS (1990) Cavernous hemangioma of the internal auditory meatus. J Otolaryngol 19:288\u2013291","journal-title":"J Otolaryngol"},{"issue":"443","key":"132_CR22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1651-2227.2003.tb00216.x","volume":"92","author":"A Mehta","year":"2003","unstructured":"Mehta A (2003) Commentary. Acta Paediatr Suppl 92(443):27","journal-title":"Acta Paediatr Suppl"},{"key":"132_CR23","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s00415-007-0575-y","volume":"254","author":"A Palla","year":"2007","unstructured":"Palla A, Hegemann S, Widmer U, Straumann D (2007) Vestibular and auditory deficits in Fabry disease and their response to enzyme replacement therapy. J Neurol 254:1433\u20131442","journal-title":"J Neurol"},{"key":"132_CR24","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/ana.20423","volume":"57","author":"F Pico","year":"2005","unstructured":"Pico F, Labreuche J, Touboul PJ, Leys D, Amarenco P (2005) Intracranial arterial dolichoectasia and small-vessel disease in stroke patients. Ann Neurol 57:472\u2013479","journal-title":"Ann Neurol"},{"key":"132_CR25","first-page":"776","volume":"85","author":"C Quick","year":"1976","unstructured":"Quick C (1976) Hearing loss in patients with dialysis and renal transplants. Ann Otol 85:776\u2013790","journal-title":"Ann Otol"},{"key":"132_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/brain\/awl310","volume":"130","author":"M Ries","year":"2007","unstructured":"Ries M, Kim HJ, Zalewski CK et al (2007) Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease. Brain 130:143\u2013150","journal-title":"Brain"},{"key":"132_CR27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/000348948909800509","volume":"98","author":"P Schachern","year":"1989","unstructured":"Schachern P, Shea D, Paparella M, Yoon T (1989) Otologic histopathology of Fabry\u2019s disease. Ann Otol Rhinol Laryngol 98:359\u2013363","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"132_CR28","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"R Schiffmann","year":"2001","unstructured":"Schiffmann R, Kopp JB, Austin HA et al (2001) Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 285:2743\u20132749","journal-title":"JAMA"},{"key":"132_CR29","first-page":"87","volume":"30","author":"B Sergi","year":"2010","unstructured":"Sergi B, Conti G, Paludetti G, Interdisciplinary Study Group On Fabry Disease (2010) Inner ear involvement in Anderson-Fabry disease: long-term follow-up during enzyme replacement therapy. Acta Otorhinolaryngol Ital 30:87\u201393","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"132_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1046\/j.0307-7772.2001.00464.x","volume":"26","author":"P Stavroulaki","year":"2001","unstructured":"Stavroulaki P, Nikolopoulos TP, Psarommatis I, Apostolopoulos N (2001) Hearing evaluation with distortion-product otoacoustic emissions in young patients undergoing haemodialysis. Clin Otolaryngology 26:235\u2013242","journal-title":"Clin Otolaryngology"},{"key":"132_CR31","doi-asserted-by":"publisher","first-page":"e598","DOI":"10.1371\/journal.pone.0000598","volume":"2","author":"AC Vedder","year":"2007","unstructured":"Vedder AC, Linthorst GE, Houge G et al (2007) Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2\u00a0mg\/kg. PLoS One 2:e598","journal-title":"PLoS One"},{"key":"132_CR32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","volume":"93","author":"WR Wilcox","year":"2008","unstructured":"Wilcox WR, Oliveira JP, Hopkin RJ et al (2008) Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab 93:112\u2013128","journal-title":"Mol Genet Metab"}],"container-title":["JIMD Reports","JIMD Reports - Case and Research Reports, 2012\/4"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/8904_2012_132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T22:52:29Z","timestamp":1713739949000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/8904_2012_132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9783642324413","9783642324420"],"references-count":32,"URL":"https:\/\/doi.org\/10.1007\/8904_2012_132","relation":{},"ISSN":["2192-8304","2192-8312"],"issn-type":[{"type":"print","value":"2192-8304"},{"type":"electronic","value":"2192-8312"}],"subject":[],"published":{"date-parts":[[2012]]}}}